Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons ; : 270-275, 2011.
Article in Korean | WPRIM | ID: wpr-785067
3.
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons ; : 178-182, 2010.
Article in Korean | WPRIM | ID: wpr-784959
4.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 128-133, 2010.
Article in Korean | WPRIM | ID: wpr-186965

ABSTRACT

Mesenchymal chondrosarcoma is very aggressive and represents approximately 1% of all chondrosarcomas. While it affects a very wide age range, the peak frequency is in the second decade of life. It may occur in the head and rib region with a predilection for the maxillofacial skeleton. The small cell undifferentiated component may assume a hemangiopericytoma-like vascular pattern and should be distinguished from hemangiopericytoma. Treatment is en bloc resection, the intended tissue margins of excision should be designed to extend well beyond the actual tumor margin, as mesenchymal chondrosarcomas. Aggressive behavior of mesenchymal chondrosarcoma of the jaw, with a tendency for delayed recurrence and metastasis even many years after treatment. The most frequent site of metastasis was the lung. Here we present 52 years old , female case of mesenchymal chondrosarcoma occurs on Rt. mandible.


Subject(s)
Female , Humans , Chondrosarcoma , Chondrosarcoma, Mesenchymal , Head , Hemangiopericytoma , Jaw , Lung , Mandible , Neoplasm Metastasis , Recurrence , Ribs , Skeleton
5.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 291-302, 2010.
Article in English | WPRIM | ID: wpr-191903

ABSTRACT

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a side effect of Bisphosphonates (BPs) use. These days, oral bisphosphonates are normally prescribed to treat osteoporosis. Intravenous BPs are used extensively to treat osteolytic bone lesions related to multiplemyeloma and bone metastasis of solid cancers, breast cancer or prostate cancer. As the prescription of BPs is universalized and the number of people treated with BPs is increasing, an accurate understanding and proper management of BRONJ are required. The aim of this study was to improve the clinicians'understanding of BRONJ by reviewing the literature. To achieve this, this paper introduces case reports as well as the current concept of BRONJ based on the 2009 updates by American Association of Oral and Maxillofacial (AAOMS) including the definition, epidemiology, etiology, diagnosis, treatment and prevention of BRONJ.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw , Breast Neoplasms , Diphosphonates , Jaw Diseases , Neoplasm Metastasis , Osteonecrosis , Osteoporosis , Prescriptions , Prostatic Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL